Ridaforolimus CAS: 572924-54-0

CAS NO: 572924-54-0
Ridaforolimus
CBNumber: CB72462148
Chemical Name: 42-(Dimethylphosphinate)rapamycin
Molecular Formula: C53H84NO14P
Formula Weight: 990.21
CAS No.: 572924-54-0
Description Review
Description

Ridaforolimus is a medication used in the treatment of various types of cancer. It belongs to the class of drugs known as mammalian target of rapamycin (mTOR) inhibitors. The chemical name of Ridaforolimus is (2S)-8-chloro-2-(4-methoxy-7-methyl-1H-indol-3-yl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one, and its molecular formula is C24H25ClN6O2. Its formula weight is 469.95 g/mol, and its CAS number is 572924-54-0.

Top Ten Keywords from Google Search:

  1. Ridaforolimus Uses
  2. Ridaforolimus Dosage
  3. Ridaforolimus Mechanism of Action
  4. Ridaforolimus Side Effects
  5. Ridaforolimus Interactions
  6. Ridaforolimus Contraindications
  7. Ridaforolimus Dosing
  8. Ridaforolimus Brand Name
  9. Ridaforolimus Safety Profile
  10. Ridaforolimus Pharmacokinetics

Synonyms of Ridaforolimus:

  • Taltorvic
  • MK-8669
  • Deforolimus
  • AP23573
  • RIDA

Health Benefits of Ridaforolimus: Ridaforolimus works by inhibiting the activity of mTOR, a protein that plays a crucial role in regulating cell growth and division. By doing so, it can slow down or stop the growth of cancer cells. Ridaforolimus has been shown to be effective in the treatment of various types of cancer, including soft tissue sarcoma, endometrial cancer, and bone cancer.

Potential Effects of Ridaforolimus: The use of Ridaforolimus can lead to a decrease in the size of tumors and an improvement in overall survival in some patients with advanced cancer. It may also help to prevent the spread of cancer to other parts of the body.

Product Mechanism: Ridaforolimus is a selective inhibitor of mTOR, a protein that regulates cell growth and division. By inhibiting the activity of mTOR, Ridaforolimus can slow down or stop the growth of cancer cells, which may help to control the progression of the disease.

Safety: Ridaforolimus is generally safe and well-tolerated when taken as directed. However, like all medications, it can cause side effects in some people. It is important to speak with your doctor about any concerns you may have about taking this medication. Ridaforolimus is contraindicated in pregnant women and patients with a history of hypersensitivity to any components of the drug or its analogs.

Side Effects of Ridaforolimus: Common side effects of Ridaforolimus include nausea, vomiting, diarrhea, fatigue, and decreased appetite. Less common side effects can include abdominal pain, headache, and muscle weakness. In rare cases, Ridaforolimus can cause serious side effects, such as lung problems, high blood sugar, and kidney damage.

Dosing Information: The recommended dose of Ridaforolimus varies depending on the type of cancer being treated and other individual factors. It is typically administered orally once daily, with or without food. It is important to follow the dosing instructions provided by your doctor to ensure that you receive the maximum benefit from this medication.

Conclusion: Ridaforolimus is a useful medication for the treatment of various types of cancer. It works by inhibiting the activity of mTOR, which slows down or stops the growth of cancer cells. While Ridaforolimus is generally safe and well-tolerated, it can cause side effects in some people. If you are concerned about taking this medication, speak with your doctor about your options

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code
Message Us